EverQuote, Inc. (NASDAQ:EVER - Free Report) - Stock analysts at Zacks Research increased their Q4 2024 earnings estimates for shares of EverQuote in a research note issued on Monday, November 18th. Zacks Research analyst T. De now expects that the company will post earnings of $0.08 per share for the quarter, up from their prior forecast of $0.07. The consensus estimate for EverQuote's current full-year earnings is $0.69 per share. Zacks Research also issued estimates for EverQuote's Q1 2025 earnings at $0.15 EPS, Q3 2025 earnings at $0.24 EPS, Q4 2025 earnings at $0.17 EPS, FY2025 earnings at $0.72 EPS and FY2026 earnings at $0.97 EPS.
EverQuote (NASDAQ:EVER - Get Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.09. The firm had revenue of $144.53 million for the quarter, compared to analysts' expectations of $140.30 million. EverQuote had a return on equity of 13.94% and a net margin of 3.31%. The company's revenue was up 162.7% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.40) EPS.
A number of other equities research analysts have also issued reports on the stock. Needham & Company LLC raised their price target on shares of EverQuote from $30.00 to $38.00 and gave the stock a "buy" rating in a report on Tuesday, August 6th. Craig Hallum raised their target price on EverQuote from $30.00 to $33.00 and gave the stock a "buy" rating in a research note on Tuesday, August 6th. JPMorgan Chase & Co. lowered their price target on EverQuote from $34.00 to $28.00 and set an "overweight" rating for the company in a research report on Tuesday, November 5th. Finally, B. Riley cut their price objective on EverQuote from $36.50 to $29.00 and set a "buy" rating on the stock in a research report on Tuesday, November 5th. Six analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $28.50.
Read Our Latest Research Report on EverQuote
EverQuote Stock Performance
Shares of EVER stock traded up $0.35 on Wednesday, hitting $19.14. 174,527 shares of the company's stock traded hands, compared to its average volume of 473,290. The stock has a market capitalization of $676.62 million, a price-to-earnings ratio of 55.26 and a beta of 1.06. The company's fifty day simple moving average is $19.80 and its 200 day simple moving average is $21.74. EverQuote has a one year low of $8.18 and a one year high of $28.09.
Institutional Trading of EverQuote
A number of hedge funds have recently bought and sold shares of EVER. Barclays PLC boosted its position in EverQuote by 331.2% during the third quarter. Barclays PLC now owns 50,983 shares of the company's stock valued at $1,076,000 after purchasing an additional 39,160 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of EverQuote by 10.4% during the third quarter. Geode Capital Management LLC now owns 595,155 shares of the company's stock valued at $12,554,000 after buying an additional 56,114 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new stake in shares of EverQuote in the 3rd quarter valued at about $757,000. MML Investors Services LLC purchased a new position in shares of EverQuote in the 3rd quarter worth approximately $290,000. Finally, Zacks Investment Management raised its stake in shares of EverQuote by 249.8% during the 3rd quarter. Zacks Investment Management now owns 52,067 shares of the company's stock worth $1,098,000 after acquiring an additional 37,182 shares in the last quarter. Hedge funds and other institutional investors own 91.54% of the company's stock.
Insiders Place Their Bets
In other EverQuote news, CTO David Brainard sold 1,641 shares of the stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $20.22, for a total transaction of $33,181.02. Following the transaction, the chief technology officer now directly owns 155,491 shares in the company, valued at $3,144,028.02. This represents a 1.04 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director George R. Neble sold 2,500 shares of the company's stock in a transaction that occurred on Thursday, October 10th. The stock was sold at an average price of $19.42, for a total transaction of $48,550.00. Following the completion of the sale, the director now directly owns 54,970 shares of the company's stock, valued at $1,067,517.40. The trade was a 4.35 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 7,003 shares of company stock worth $139,387 over the last quarter. Company insiders own 29.79% of the company's stock.
EverQuote Company Profile
(
Get Free Report)
EverQuote, Inc operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc, and changed its name to EverQuote, Inc in November 2014.
Featured Articles
Before you consider EverQuote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EverQuote wasn't on the list.
While EverQuote currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.